Synonyms: OPC-167832
Compound class:
Synthetic organic
Comment: Quabodepistat is a 3,4-dihydrocarbostyril derivative. It is an inhibitor of decaprenylphosphoryl-beta-D-ribose oxidase (DprE1), an essential mycobacterial cell wall biosynthesis enzyme, and has potent antimycobacterial activity [3]. Quabodepistat is under clinical development by Otsuka Pharmaceutical (Tokyo, Japan) as a treatment for tuberculosis (TB).
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
5-[[(3R,4R)-1-(4-chloro-2,6-difluorophenyl)-3,4-dihydroxypiperidin-4-yl]methoxy]-8-fluoro-3,4-dihydro-1H-quinolin-2-one |
International Nonproprietary Names | |
INN number | INN |
11737 | quabodepistat |
Synonyms |
OPC-167832 |
Database Links | |
Specialist databases | |
Antibiotic DB | OPC-167832 |
Other databases | |
CAS Registry No. | 1883747-71-4 (source: Scifinder) |
ChEMBL Ligand | CHEMBL5095080 |
DrugBank Ligand | DB17770 |
GtoPdb PubChem SID | 491299841 |
PubChem CID | 118904282 |
Search Google for chemical match using the InChIKey | XZISSTDXPBUCJA-DYESRHJHSA-N |
Search Google for chemicals with the same backbone | XZISSTDXPBUCJA |
Search PubMed clinical trials | quabodepistat |
Search PubMed titles | quabodepistat |
Search PubMed titles/abstracts | quabodepistat |
UniChem Compound Search for chemical match using the InChIKey | XZISSTDXPBUCJA-DYESRHJHSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | XZISSTDXPBUCJA-DYESRHJHSA-N |